Skip to main content

Delete supply plan alert

A supply plan represents a set of parameters such as item units, stock values, and so on that is configured to automate the process of item supply to sites to always maintain a sufficient amount of medication or devices for all registered subjects. A supply plan alert is a customizable notification mechanism that generates an email to inform relevant parties when a different supply plan is assigned to some study site.

The purpose of the supply plan alert is to keep the site personnel informed about any modifications to the planned item supply so they can manage inventory and distribution effectively during the study. However, it may occur that the configured supply plan alert needs to be deleted due to updates in supply management processes or other evolving study requirements.

To delete the supply plan alert

  1. In the IWRS application header, select the ALERT tab.

  2. On the page that opens, from the left pane, select the subtab corresponding to the alert category of your interest.

    Accessing alert settings
    Figure 1. Accessing alert settings

  3. In the Supply Plan Alert table that appears, next to the configured supply plan alert, select More more_icon.png > Delete trash_can_icon.png.

    Selecting option to delete supply plan alert
    Figure 2. Selecting option to delete supply plan alert

  4. In the Delete Item confirmation dialog that appears, select delete_button_white_red.png.

    Confirming supply plan alert deletion
    Figure 3. Confirming supply plan alert deletion

Once confirmed, the supply plan alert is deleted. The system no longer generates emails since there is no supply plan alert.

In this section:

An investigational product that is used in a study. In eClinical, it can be viewed as an equivalent to a drug name to distinguish items at all stages of their lifecycle—manufacturing, shipment, dispensation to subjects, or else.

Another name for the item unit in the IWRS system is product unit.

In a clinical trial, a location where the subject treatment and drug dispensation occur. It can be a hospital, a private laboratory, or other institutions.

A participant who is enrolled in a clinical trial and assigned to the site.